Trybe Capital Management LP Ginkgo Bioworks Holdings, Inc. Transaction History

Trybe Capital Management LP

  • $742 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.14 - $1.95 $3.11 Million - $5.32 Million
2,726,433 Added 258.59%
3,780,776 $7.03 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $2.19 $1.27 Million - $2.31 Million
1,054,343 New
1,054,343 $1.4 Million
Q2 2022

Aug 15, 2022
SELL
$2.2 - $4.2 $338,027 - $645,325
-153,649 Reduced 12.72%
1,054,343 $2.51 Million
Q3 2021

Nov 15, 2021
BUY
$9.15 - $13.28 $11.1 Million - $16 Million
1,207,992 New
1,207,992 $14 Million

Others Institutions Holding DNA

# of Institutions
29
Shares Held
48M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13.9B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Trybe Capital Management LP Portfolio

Follow Trybe Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trybe Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Trybe Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email